Terms and concepts: Difference between revisions
Appearance
Make the 2025 medico-pharmaceutical law book discoverable |
Use English explanations and translated titles while preserving source identification |
||
| Line 2: | Line 2: | ||
== Law, medicines and professional practice == | == Law, medicines and professional practice == | ||
* [[Medical law]] | * [[Medical law]]: healthcare rights, responsibilities and accountability. | ||
* [[Pharmaceutical law]] | * [[Pharmaceutical law]]: medicines and pharmaceutical activities. | ||
* [[Medico-pharmaceutical law]] | * [[Medico-pharmaceutical law]]: an integrated approach developed in the research programme. | ||
* '''[[The Concept of Medico-Pharmaceutical Law: Principles, Advantages and Risks of Integration]]''' (2025): the monograph developing the integrated approach. [https://books.sreif.us/index.php/sreif/catalog/book/10 Read the book / publisher record]. | * '''[[The Concept of Medico-Pharmaceutical Law: Principles, Advantages and Risks of Integration]]''' (2025): the monograph developing the integrated approach. [https://books.sreif.us/index.php/sreif/catalog/book/10 Read the book / publisher record]. | ||
* [[Medicines control regime]] | * [[Medicines control regime]]: the relationship of pharmacological and legal classifications. | ||
* [[Safe self-medication]] | * [[Safe self-medication]]: safeguards, professional support and the limits of non-prescription medicine use. | ||
* [[Pharmaceutical law in safe self-medication]] — the 1998, 2005 and 2010 book lineage. | * [[Pharmaceutical law in safe self-medication]] — the 1998, 2005 and 2010 book lineage. | ||
Revision as of 00:10, 12 November 2026
This index connects explanatory articles with the books and journal research from which this wiki is developing. It distinguishes general fields of study, source-specific analytical tools and proposals developed in Vision 2035.
Law, medicines and professional practice
- Medical law: healthcare rights, responsibilities and accountability.
- Pharmaceutical law: medicines and pharmaceutical activities.
- Medico-pharmaceutical law: an integrated approach developed in the research programme.
- The Concept of Medico-Pharmaceutical Law: Principles, Advantages and Risks of Integration (2025): the monograph developing the integrated approach. Read the book / publisher record.
- Medicines control regime: the relationship of pharmacological and legal classifications.
- Safe self-medication: safeguards, professional support and the limits of non-prescription medicine use.
- Pharmaceutical law in safe self-medication — the 1998, 2005 and 2010 book lineage.
Research, quality and access
- Pharmacopoeial standards: testing standards and quality infrastructure.
- Pharmacoeconomic analysis: resource use and pharmaceutical-management analysis.
- Access to medicines: availability and the conditions of obtaining appropriate care.
- Continuity of pharmaceutical supply: legal and organizational resilience during disruption.
- Organizational and legal analysis: connecting rules with professional and institutional activity.
Economics, education and public administration
- State support and economic resilience: distinct support mechanisms during disruption.
- Professional qualification structure: distributions of occupations and qualifications.
- Digital competences and employment policy: education, adaptation and policy proposals.
Intellectual contribution and conceptual development
- US copyright registration: the 2025 monograph, its registration and the distinction from a patent.
- Evolving Authorship: a proposed account of contributions across versions.
- Recipra, All-Being Security and Vision 2035: separately documented conceptual developments.
For article-level sources and starting dates of each journal, see Journal research map. This is a growing reference index, not an exhaustive dictionary or a substitute for current legal and clinical advice.